Lubiprostone Significantly Improves Symptom Relief Rates in Adults With Irritable Bowel Syndrome and Constipation (IBS-C): Data from Two Twelve-Week, Randomized, Placebo-Controlled, Double-Blind Trials

@inproceedings{Drossman2007LubiprostoneSI,
  title={Lubiprostone Significantly Improves Symptom Relief Rates in Adults With Irritable Bowel Syndrome and Constipation (IBS-C): Data from Two Twelve-Week, Randomized, Placebo-Controlled, Double-Blind Trials},
  author={Douglas A. Drossman and William D. Chey and Raymond Michael Panas and Aimee Wahle and Charles Scott and Ryuji Ueno},
  year={2007}
}
  • Douglas A. Drossman, William D. Chey, +3 authors Ryuji Ueno
  • Published 2007
  • Medicine
  • Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Topics from this paper.

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 19 CITATIONS

    Review: The treatment of irritable bowel syndrome

    VIEW 19 EXCERPTS
    CITES RESULTS & METHODS
    HIGHLY INFLUENCED

    Irritable Bowel Syndrome and Constipation Agents

    • 2019
    VIEW 1 EXCERPT
    CITES BACKGROUND